StonvexLoading…
StonvexStonvexStonvexCore line items from ASH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-09-30 | Annual 2024 2024-09-30 | Annual 2023 2023-09-30 | Annual 2022 2022-09-30 |
|---|---|---|---|---|
Revenue | $1.82B | $2.11B | $2.19B | $2.39B |
Operating Income | $-775.00M | $-26.00M | $172.00M | $333.00M |
Net Income | $-845.00M | $169.00M | $178.00M | $927.00M |
EPS (Diluted) | $-18.23 | $3.36 | $3.31 | $16.41 |
Total Assets | $4.61B | $5.64B | $5.94B | $6.21B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $215.00M | $300.00M | $417.00M | $646.00M |
Free Cash Flow OCF − CapEx | $36.00M | $325.00M | $124.00M | $80.00M |
Shares Outstanding | 46.00M | 50.00M | 54.00M | 56.00M |